Amoxil - Medical drug profile

본문 바로가기


Home > Product > Amoxil - Medical drug profile
Selling leads
Amoxil - Medical drug profile
Posting date : May 20, 2026
Membership
Free Member Scince May 20, 2026
FOB Price
100
Min. Order Quantity
100
Supply Abillity
100
Port
100
Payment Terms
100
Package
500
Keyword :
Category
Contact
Prednisolone
Selling Leads Detail
Company Info
 
Quick Detail
Place of Origin
United States [US]
Brand Name
Amoxil
HS-CODE
30-
Package & Delivery Lead Time
Package
500
Detailed Description

Medical drug profile: Amoxil

Amoxicillin is a prescription antibiotic in the penicillin class. It is used to treat selected bacterial infections, including some ear infections, sinus infections, throat infections, pneumonia, urinary tract infections, skin infections, and other conditions when the bacteria are expected to be susceptible. It does not treat viral infections such as the common cold, influenza, or most routine cough illnesses.

The phrase amoxicillin pediatric dose refers to the child-specific dosing of amoxicillin. In children, amoxicillin dosing is usually based on body weight, the type of infection, infection severity, kidney function, age, and the formulation being used. A dose that is appropriate for one child may be too low or too high for another child, even if the symptoms appear similar.

Pediatric amoxicillin is commonly supplied as a liquid suspension, chewable tablet, tablet, or capsule. Liquid formulations require careful measurement with an oral syringe or dosing device, not a household spoon. Parents and caregivers should check the label concentration closely because different bottles may contain different amounts of amoxicillin per milliliter. Giving the right volume matters as much as giving the right medicine.

For ear infections, strep throat, sinus infections, and other pediatric bacterial illnesses, the treatment schedule may differ. Some infections require a higher weight-based dose, while others may need a standard dose or a different antibiotic. The prescriber may also adjust the dose if the child has kidney problems, recurrent infections, recent antibiotic exposure, or risk factors for resistant bacteria.

Amoxicillin should be given for the full prescribed course unless a healthcare professional instructs otherwise. Symptoms may improve before the infection is fully treated. Stopping early can allow bacteria to continue growing and may increase the chance that the infection returns. However, if a child develops signs of a serious reaction, medical advice should be sought promptly rather than continuing the medicine without review.

Common side effects in children may include diarrhea, nausea, vomiting, stomach discomfort, rash, or diaper-area irritation. Mild digestive upset can occur with antibiotics, but severe diarrhea, watery stools, bloody stools, fever, or strong abdominal pain should be reported because these symptoms may suggest a more serious intestinal reaction.

A rash during amoxicillin treatment needs careful interpretation. Some rashes are mild, but others may indicate allergy. Warning signs of a serious allergic reaction include hives, facial swelling, lip or tongue swelling, wheezing, throat tightness, trouble breathing, dizziness, or a widespread blistering rash. These symptoms require urgent medical attention.

Children with a known serious allergy to amoxicillin, penicillin, or certain related antibiotics should not receive amoxicillin unless a clinician has specifically evaluated the risk. Caregivers should also tell the prescriber about kidney disease, mononucleosis, previous antibiotic reactions, current medicines, and any history of severe diarrhea after antibiotics.

For amoxicillin pediatric dose, the key safety message is that dosing should be calculated for the individual child, not estimated from adult dosing or another child’s prescription. The safest approach is to use the exact prescribed strength, amount, timing, and duration, measure liquid doses accurately, and contact a healthcare professional if doses are missed, vomiting occurs after a dose, symptoms worsen, or side effects appear.


ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us
Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea
About Us Privacy Policy Terms of use Copyright © 2000-2026 ECROBOT.COM. All rights reserved.
Top